Primary Care Clinics in Deadwood, SD Accepting Medicare
5 Primary Care Clinics found. Showing 1 - 5
 Monument Health Lead-deadwood Clinic Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 71 Charles St, Deadwood, SD 57732 Phone: 605-717-6431 Fax: 605-717-8033 |
Monument Health Lead-deadwood Hospital Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 61 Charles St, Deadwood, SD 57732 Phone: 605-722-6101 |
Lead Deadwood Regional Medical Clinic Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 71 Charles St, Deadwood, SD 57732 Phone: 605-717-6431 |
Monument Health Lead-deadwood Clinic Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 71 Charles St, Deadwood, SD 57732 Phone: 605-717-6431 Fax: 605-717-8033 |
Lead-deadwood Regional Medical Clinic Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 71 Charles St, Deadwood, SD 57732 Phone: 605-717-6431 Fax: 605-719-6470 |
News Archive
Aspirus implements EMC solutions and services for data center consolidation and virtualization
EMC Corporation, the world leader in information infrastructure solutions, today announced that Aspirus, a non-profit system of hospitals, clinics and other healthcare facilities with more than 4,200 employees and more than 400 licensed inpatient beds in its system, is helping its practitioners streamline workflows while reducing IT administrative costs leveraging EMC solutions and services for data center consolidation and virtualization.
Calcium receptor – potential drug target for sleeping sickness
While its common name may make it sound almost whimsical, sleeping sickness, or African trypanosomiasis, is in reality a potentially fatal parasitic infection that has ravaged populations in sub-Saharan Africa for decades, and it continues to infect thousands of people every year.
BP and headache drug effectively speeds up treatment of TB
​Infectious disease experts at Johns Hopkins have found, in studies in mice, that a drug better known as a treatment for high blood pressure and headaches effectively speeds up treatment of TB when added to the standard, daily antibiotic regimen. Test animals were cured in four months instead of the usual six.
Positive results from Incyte's COMFORT-I INCB18424 pivotal Phase III clinical trial in myelofibrosis
Incyte Corporation announced today positive top-line results from COMFORT-I, the pivotal Phase III clinical trial of INCB18424 (also known as INC424) in patients with myelofibrosis (MF) being conducted under a Food and Drug Administration (FDA) Special Protocol Assessment (SPA) Agreement. COMFORT-I (COntrolled MyeloFibrosis Study with ORal JAK Inhibitor Treatment) is a double-blind, placebo-controlled Phase III trial involving 309 patients.
Paper highlights clinical and immunological activity of immatics' IMA901 in renal cell carcinoma
immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced that key data covering the scientific and clinical development of its lead cancer vaccine, IMA901, have been published in Nature Medicine.
› Verified 2 days ago